These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7876373)

  • 1. Stability of piperacillin sodium in the presence of tazobactam sodium in 5% dextrose and normal saline injections.
    Mathew M; Das Gupta V; Bethea C
    J Clin Pharm Ther; 1994 Dec; 19(6):397-9. PubMed ID: 7876373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shelf lives of aseptically prepared medicines--stability of piperacillin/tazobactam in PVC and non-PVC bags.
    Rigge DC; Jones MF
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):339-43. PubMed ID: 16085149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions.
    Park TW; Le-Bui LP; Chung KC; Rho JP; Gill MA
    Am J Health Syst Pharm; 1995 Sep; 52(18):2022-4. PubMed ID: 8528873
    [No Abstract]   [Full Text] [Related]  

  • 5. Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
    Moon YS; Chung KC; Chin A; Gill MA
    Am J Health Syst Pharm; 1995 May; 52(9):999-1001. PubMed ID: 7641040
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions.
    Leung E; Venkatesan N; Ly SC; Scheetz MH
    Am J Health Syst Pharm; 2013 Jul; 70(13):1163-6. PubMed ID: 23784164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
    Chung KC; Moon YS; Chin A; Ulrich RW; Gill MA
    Am J Health Syst Pharm; 1995 Jul; 52(14):1554-6. PubMed ID: 7552901
    [No Abstract]   [Full Text] [Related]  

  • 8. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
    Marselos SC; Archontaki HA
    J Pharm Biomed Anal; 2002 Jul; 29(5):787-93. PubMed ID: 12093510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ciprofloxacin in 5% dextrose and normal saline injections.
    Mathew M; Das Gupta V; Zerai T
    J Clin Pharm Ther; 1994 Aug; 19(4):261-2. PubMed ID: 7989406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination.
    Gin A; Dilay L; Karlowsky JA; Walkty A; Rubinstein E; Zhanel GG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):365-83. PubMed ID: 17547502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Mar; 51(5):672-8. PubMed ID: 8203388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Augey V; Grosse PY; Albert G; Audran M; Bressolle F
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):125-36. PubMed ID: 8832433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of vancomycin hydrochloride in 5% dextrose and 0.9% sodium chloride injections.
    Das Gupta V; Stewart KR; Nohria S
    Am J Hosp Pharm; 1986 Jul; 43(7):1729-31. PubMed ID: 3752110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-Tazobactam: a new beta-lactam-beta-lactamase inhibitor combination.
    Daniel KP; Krop LC
    Pharmacotherapy; 1996; 16(2):149-62. PubMed ID: 8820460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakpoint determination: piperacillin/tazobactam.
    Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):575-7. PubMed ID: 8404929
    [No Abstract]   [Full Text] [Related]  

  • 16. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    Sörgel F; Kinzig M
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():39-60. PubMed ID: 8383655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
    Zhang Y; Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):520-4. PubMed ID: 10932462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.
    Kempers J; MacLaren DM
    J Antimicrob Chemother; 1990 Oct; 26(4):598-9. PubMed ID: 2174855
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.
    Nicasio AM; VanScoy BD; Mendes RE; Castanheira M; Bulik CC; Okusanya OO; Bhavnani SM; Forrest A; Jones RN; Friedrich LV; Steenbergen JN; Ambrose PG
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2075-80. PubMed ID: 26787689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on penam sulfones. I. Synthesis and beta-lactamase inhibitory activity of 2 beta-alkoxycarbonyl penicillanic acid sulfones.
    Setti EL; Reddy NA; Phillips OA; Czajkowski DP; Atchison K; Atwal H; Micetich RG; Maiti SN; Kunugita C; Hyodo A
    J Antibiot (Tokyo); 1996 Sep; 49(9):944-6. PubMed ID: 8931732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.